Lee Financial and UMB Bank Alter UnitedHealth Group Stakes with $12.6M Trades
Lee Financial Co acquired 3,390 UNH shares worth $1.17M in Q3, while UMB Bank cut its holdings by 25.2%—selling 11,125 shares to hold 33,054 shares valued at $11.41M. Meridian Wealth Management sold 3,068 shares (15.2%) and Thrivent Financial trimmed its stake by 7% (34,694 shares) in the period.
1. Lee Financial Co Initiates Stake in UnitedHealth Group
In the third quarter, Lee Financial Co acquired 3,390 shares of UnitedHealth Group, marking its first reported position in the healthcare giant. The new holding carried an approximate value of $1.17 million based on prevailing market levels at quarter end. This initial allocation underscores Lee Financial’s confidence in UnitedHealth’s diversified operations across benefits administration and care delivery services.
2. Broad Institutional Activity Highlights Confidence Shift
Several other institutional investors adjusted their UnitedHealth Group exposures during recent periods. Brighton Jones LLC more than doubled its stake, adding 28,231 shares to reach a position valued at $22.38 million, while Revolve Wealth Partners LLC boosted its holding by 137.1%, acquiring 2,324 additional shares for a total cost of $2.03 million. Meanwhile, smaller entrants such as CMT Capital Markets Trading GmbH and Patriot Financial Group Insurance Agency LLC established or expanded positions valued between $340,000 and $1.66 million, reflecting a renewed appetite among diversified funds for UnitedHealth’s steady revenue growth and integrated platform.
3. Analyst Consensus Remains Favorable Despite Price Objective Adjustments
Equity research firms have maintained a predominantly bullish view on UnitedHealth Group. Among recent updates, Jefferies trimmed its price target to $340 while reaffirming a buy recommendation, and Oppenheimer lowered its target to $385 but kept an outperform stance. Collectively, one analyst rates the stock as a strong buy, seventeen as buy, nine as hold and two as sell, yielding an average target near $377. These forecasts reflect expectations for stable earnings progression supported by 12.3% revenue growth in the latest quarter.
4. Solid Quarterly Results and Full-Year Guidance Underpin Outlook
In its latest quarterly report, UnitedHealth Group delivered earnings per share of $2.11, narrowly exceeding consensus by $0.02, on revenue of $113.22 billion, up 12.3% year-on-year. Net margin stood at 2.69% and return on equity at 14.79%. Management set full-year guidance at approximately 17.75 EPS, while sell-side forecasts cluster around 29.54 EPS for the current year. Additionally, the company’s annualized dividend of $8.84, representing a 3.1% yield, reinforces its commitment to shareholder returns.